Neurovascular Devices/Interventional Neurology - Forecast(2021 - 2026)

Report Code: HCR 0571 Report Format: PDF + Excel (Delivery in 48 Hrs)

Neurovascular Devices/Interventional Neurology Market Overview

The Neurovascular Devices/Interventional Neurology Market size is estimated to reach $3.4 Bn by 2025, growing at a CAGR of 9.1% during the forecast period 2020-2025. Neurovascular/interventional neurology devices are used to treat several neurovascular diseases including aneurysms, arteriovenous malformations, atherosclerosis, and moyamoya diseases that affect the Blood Vascular system as well as the Central Nervous system associated with it. Factors such as favorable medical reimbursements large target patient population base, ongoing product development & commercialization, and expansion of healthcare infrastructure is driving the growth of Neurovascular Devices/Interventional Neurology Market during the forecast period 2020-2025.

Neurovascular Devices/Interventional Neurology Market Report Coverage

The report: “Neurovascular Devices/Interventional Neurology Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Neurovascular Devices/Interventional Neurology Market. 
By Product Type: Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices, Support devices, Neurothrombectomy Devices.
By Disease Type: Arteriovenous Malformation and Fistulas, Ischemic Strokes, Cerebral Aneurysms, and Other Disease Pathologies.
By End User Type: Hospitals, Specialty Clinics, and Ambulatory Surgical Units.
By Geography: North America, Asia-Pacific, Europe, and Rest of World.

Key Takeaways

  • Geographically, North America held largest market share in the Neurovascular Devices/Interventional Neurology Market in 2019. This is owing to the increasing number of clinical trial and large patient population for target diseases.
  • The factors such as the increasing number of research activities in the field of neurovascular therapies and rising demand for minimally invasive neurosurgical procedures are set to offer renewed growth opportunities for the market players during the forecast period 2020-2025. 
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Neurovascular Devices/Interventional Neurology Market report.

Neurovascular Devices/Interventional Neurology Market Segment Analysis - By Product Type

Based on Product Type, Neurovascular Devices/Interventional Neurology Market is segmented into Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices, Support devices and Neurothrombectomy Devices. Aneurysm Coiling & Embolization Devices hold the major share in the market in 2019. This is Owing to the growing End User performance for neurosurgical procedures and increasing market and availability of embolic coils for neurovascular treatment. Moreover Rising demand for minimally invasive neurosurgical procedures is driving the Aneurysm Coiling & Embolization Devices and is set to be the fastest growing with a CAGR of 9.95% during the forecast period 2020-2025.

Neurovascular Devices/Interventional Neurology Market Segment Analysis - By Disease

Based on Disease Type, Neurovascular Devices/Interventional Neurology Market is segmented into Arteriovenous Malformation and Fistulas, Ischemic Strokes, Cerebral Aneurysms, and Other Disease Pathologies. The Ischemic Strokes segment is set to be the fastest-growing CAGR during the forecast period 2020-2025 this is owing to improved minimally invasive procedures demand, and expansion in health care. 

Neurovascular Devices/Interventional Neurology Market Segment Analysis - By Geography

Based on Geography the Neurovascular Devices/Interventional Neurology Market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America had a largest share in terms of revenue in 2019 with a share of 40.7%.  This is owing to high adoption rate of neurovascular devices and presence of major key manufacturers in this region. Asia Pacific is set to be the fastest-growing market during the forecast period 2020-2025. This is owing to increasing healthcare expenditure on healthcare domain and increasing manufacturers in this region

Neurovascular Devices/Interventional Neurology Market Drivers  

Rising popularity of neurovascular diseases:

The brain consumes one fifth of body’s energy and nutrients the cerebrovascular system plays a key role in supporting the brain by providing oxygen and nutrients to the brain. Any abnormalities occurring in the cerebral microvasculature is set to affect the integrity of brain functioning. This relationship is best appreciated based on the concept of the neurovascular unit (NVU), which comprises multiple cell types, including neurons, vascular smooth muscle cells, endothelial cells, astrocytes, microglia, and pericytes. With increasing such incidence of Neurovascular diseases, the Neurovascular Devices/ Interventional Neurology Market is set to drive the demand during the forecast period 2020-2025.

Neurovascular Devices/Interventional Neurology Market Challenges

Challenges such as Ethical decision making, Risk of moral injury and treatment priority settings, as well as medico-legal risks, and financial uncertainties. 

Neurovascular Devices/Interventional Neurology Market Industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Neurovascular Devices/Interventional Neurology Market. Key companies of this market are W.L. Gore & Associates, Inc, Abbott Laboratories, Stryker Corporation, Medtronic PLC, Terumo Corporation, Johnson & Johnson, Penumbra, Inc, Boston Scientific Corporation, Merit Medical Systems, Inc, and Microport Scientific Corporation among others.

Neurovascular Devices/Interventional Neurology Market Developments: 

In January 2017, Abbott Laboratories has acquired St. Jude Medical The transaction provides Abbott with expanded opportunities for future growth and is an important part of the company's ongoing effort to develop a strong, diverse portfolio of Neurovascular devices, diagnostics, nutritionals and branded generic pharmaceuticals.


For more Lifesciences and Healthcare related reports, please click here
1. Neurovascular Devices/Interventional Neurology Market Overview
    1.1 Definitions and Scope
2. Neurovascular Devices/Interventional Neurology Market Executive Summary
    2.1 Market revenue, Market Size and Key Trends 
    2.2 Key trends by Product Type
    2.3 Key trends by Disease Type
    2.4 Key trends by End User Type
    2.5 Key trends by Geography
3. Neurovascular Devices/Interventional Neurology Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies  
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Neurovascular Devices/Interventional Neurology Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Neurovascular Devices/Interventional Neurology Market - Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Neurovascular Devices/Interventional Neurology Market Forces
    6.1 Market Drivers
    6.2 Market Constraints and Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. Neurovascular Devices/Interventional Neurology Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Neurovascular Devices/Interventional Neurology Market – By Product Type(Market Size -$Million/$Billion)
    8.1 Cerebral Balloon Angioplasty and Stenting Systems
        8.1.1 Carotid Artery Stents
        8.1.2 Embolic Protection Systems
            8.1.2.1 Distal Filter Devices
            8.1.2.2 Balloon Occlusion Devices
    8.2 Aneurysm Coiling & Embolization Devices
        8.2.1 Embolic Coils
        8.2.2 Bare Detachable Coils
        8.2.3 Coated Detachable Coils
    8.3 Support Devices
        8.3.1 Microcatheters
        8.3.2 Microguidewires
    8.4 Neurothrombectomy Devices
       8.4.1 Clot Retrieval Devices
       8.4.2 Suction and Aspiration Devices
       8.4.3 Snares
9. Neurovascular Devices/Interventional Neurology Market – By  Disease  (Market Size -$Million/$Billion)
    9.1 Arteriovenous Malformation and Fistulas
    9.2 Ischemic Strokes
    9.3 Cerebral Aneurysms
    9.4 Other Disease Pathologies
10. Neurovascular Devices/Interventional Neurology Market – By  End User  (Market Size -$Million/$Billion)
    10.1 Hospitals
    10.2 Specialty Clinics
    10.3 Ambulatory Surgical Units
11. Neurovascular Devices/Interventional Neurology Market - By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Netherlands
        11.2.5 Spain
        11.2.6 Belgium
        11.2.7 Italy
        11.2.8 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 India
        11.3.4 South Korea
        11.3.5 Australia
        11.3.6 New Zealand
        11.3.7 Rest of Asia Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Neurovascular Devices/Interventional Neurology Market Entropy
13. Neurovascular Devices/Interventional Neurology Market - Industry / Segment Competition landscape Premium Premium
    13.1 Market Share Analysis
        13.1.1 Market Share by Country- Key companies
        13.1.2 Market Share by Region- Key companies
        13.1.3 Market Share at Global Level- Key companies
        13.1.4 Best Practices for Companies
14. Neurovascular Devices/Interventional Neurology Market - Key Company List by Country Premium Premium
15. Neurovascular Devices/Interventional Neurology Market Company Analysis
    15.1 (Company Revenue, Products, M&A, Developments)
    15.2 W.L. Gore & Associates, Inc.
    15.3 Abbott Laboratories
    15.4 Stryker Corporation
    15.5 Medtronic PLC
    15.6 Terumo Corporation
    15.7 Johnson & Johnson
    15.8 Penumbra, Inc.
    15.9 Boston Scientific Corporation
    15.10 Merit Medical Systems, Inc.
    15.11 Microport Scientific Corporation
"*Financials for private companies would be provided on a best efforts basis”.